Navigation Links
Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
Date:10/22/2007

Stent (p=0.01), reflecting an increased number of small (non-Q wave) MIs at the time of the procedure (2.5% vs. 3.8%).

Subset analysis showed especially strong performance of the TAXUS Stent in diabetic patients with MACE rates remaining low at 4.7%, while MACE rates increased in the XIENCE V (PROMUS) Stent to 8.8%. In long lesions (lesion length>13.2 mm), MACE was 7.7% for the XIENCE V (PROMUS) Stent and 8.0% for the TAXUS Stent; in small vessels (RVD< / =2.775 mm), 6.1% for the XIENCE V (PROMUS) Stent and 12.1% for the TAXUS Stent*.

Stent thrombosis rates through one year were also low for both the TAXUS Stent (0.6%, 0.6%) and the XIENCE V (PROMUS) Stent (0.8%, 1.1%), using protocol and ARC definitions, respectively.

"The SPIRIT III one-year data reaffirms the proven long-term outcomes of the TAXUS Stent," said Paul LaViolette, Chief Operating Officer of Boston Scientific. "We look forward to launching the PROMUS Stent in the U.S., which will complement our paclitaxel-eluting TAXUS Stent by offering physicians a deliverable Olimus option."

The PROMUS Stent has CE Mark approval and is distributed in most European countries and other international markets. The PROMUS Stent is an investigational device in the U.S. and not yet approved for sale. It is currently under FDA review with an anticipated U.S. launch in 2008. The safety and efficacy of the TAXUS Express2 Stent System have not been established in patients with diabetes, long lesions and small vessels.

SPIRIT is sponsored by Abbott. TAXUS, Express2 and PROMUS are trademarks of Boston Scientific Corporation or its affiliates. XIENCE is a trademark of Abbott Laboratories Group of Companies.

*Subsets were not designed for statistical comparisons and demonstrated the above observational results.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more inf
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Announces Schedule for EuroPcr 2007
2. Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
7. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
10. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
11. Inspire Announces Presentations at Two European Scientific Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... The market for both conventional and digital ... in 2014 according to Kalorama Information.  The healthcare market ... incidence of disease are driving the market.  The finding ... X-Ray: World Market Analysis . ... can be obtained at: http://www.kaloramainformation.com/Ray-Digital-8507029/ ...
(Date:11/28/2014)... 30 September 201430 September 2013Turnover 546,011 , 534,641 , ... , 339,113 , 13.3 Hospital Management Service ... 49.5 Medical Insurance Administration Service Income , 2,394 ... Sales , 94,580 , 142,683 , ... 9,219 , (68.4) Impairment Loss on Fixed Assets ...
(Date:11/26/2014)...   Royal Philips (NYSE: ... of its portfolio of diagnostic X-ray solutions ... , ProGrade and PrimaryDiagnost[ii]. With new releases of ... U.S., and availability of all these solutions in ... innovative solutions designed to meet the needs and ...
Breaking Medicine Technology:Kalorama: X-Ray and Digital X-Ray Market Nears 8 Billion This Year 2Kalorama: X-Ray and Digital X-Ray Market Nears 8 Billion This Year 3Golden Meditech Announces 2014 / 2015 Interim Results 2Golden Meditech Announces 2014 / 2015 Interim Results 3Golden Meditech Announces 2014 / 2015 Interim Results 4Golden Meditech Announces 2014 / 2015 Interim Results 5Golden Meditech Announces 2014 / 2015 Interim Results 6Golden Meditech Announces 2014 / 2015 Interim Results 7Golden Meditech Announces 2014 / 2015 Interim Results 8Philips expands global reach of diagnostic X-Ray solutions 2Philips expands global reach of diagnostic X-Ray solutions 3
(Date:11/29/2014)... 29, 2014 ... both qualitative and quantitative analysis ... strategies preferred by key market ... the growth, and restraints in ... the opportunities in the baking ...
(Date:11/28/2014)... 2014 The emerging blend ... research in all the healthcare segments such ... support and population health management. The demand ... innovation in machine learning, logical methodologies, computational ... full report with full table of contents ...
(Date:11/28/2014)... Tbdress.com has recently announced its ... on Nov. 28, 2014. The special offer will provide ... more) at greatly discounted prices. , The website ... holiday, celebrated generally on December 25 by billions of ... sales, are always provided in December.” , Tbdress.com ...
(Date:11/28/2014)... Recently, SWAccessControl.com, a renowned smartware manufacturer, has ... all these high end products are offered at discounted ... will last from today to Dec 16, 2014. , ... launch the promotion. We are proud of our new ... latest information about our hottest items, we have listed ...
(Date:11/28/2014)... FL (PRWEB) November 28, 2014 The month ... over 20,000 car accidents occurring in Florida every year ... on the importance of auto insurance policies. , "Optional auto ... drop. Auto insurance is not cheap I know, actually Florida ... the costs are even higher, but what I see is ...
Breaking Medicine News(10 mins):Health News:Global Baking Ingredients Market with an Analysis and Forecast to 2019 - New Research Report Available at ReportsnReports.com 2Health News:Global Baking Ingredients Market with an Analysis and Forecast to 2019 - New Research Report Available at ReportsnReports.com 3Health News:Global Baking Ingredients Market with an Analysis and Forecast to 2019 - New Research Report Available at ReportsnReports.com 4Health News:Medical & Healthcare Analytics Market Report: Global Industry Size, Share, Trends, Growth and Forecast by Researchmoz.us 2Health News:Tbdress.com Announced Its Christmas Eve Sales 2Health News:New Access Control Systems Now Offered At Low Prices By Smartware Manufacturer SWAccessControl.com 2Health News:Car Accident Attorney Sean M. Cleary on Auto Insurance Policies Essential for Florida Drivers 2
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today ... PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) for the treatment ... the Phase 2 clinical study in late June or ... the clinical trial sites. The U.S. Food and ...
... on Tumors and Tumor Blood Vessel Cells , ... subsidiary of Eisai Corporation of North America, announced that ... investigational new drug (IND) application to study MORAb-004 in ... endosialin, a protein expressed on cells associated with tumors ...
... June 9 Bruce Matter has joined healthcare IT ... for company growth and client satisfaction. Peminic, with offices ... process management solutions to over 400 acute care and ... management and legal matters. , , Teaming with ...
... Million From 2008 to 2018, According to a New Report ... Decision Resources, one of the world,s leading research and ... in the Parkinson,s disease drug market, fueled by the launch ... generic erosion of key currently-available agents. As a result, sales ...
... American Diabetes Association Meeting Validate Mechanistic and Therapeutic Potential ... , , SOUTH SAN FRANCISCO, Calif., June 9 ... three posters that validate the mechanistic activity and therapeutic ... orally-administered soluble epoxide hydrolase (sEH) inhibitor that is in ...
... Four Locations to Hold Discussions on Aging in Place throughout ... , WASHINGTON, June 9 As part of a national ... America will be hosting workshops throughout the month of June, ... Americans remain in their communities. , , Attendees ...
Cached Medicine News:Health News:Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study 2Health News:Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study 3Health News:Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study 4Health News:Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors 2Health News:Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors 3Health News:Industry Recognized and Trusted Leader, Bruce Matter, Joins Healthcare IT Company, Peminic, Inc. as Company Growth in the Areas of Patient Safety, Risk Management, and Patient Satisfaction Accelerates 2Health News:Growth in the Parkinson's Disease Drug Market, Fueled by the Launch of Several New Therapies, Will be Offset by Generic Erosion of Key Agents 2Health News:Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 2Health News:Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 3Health News:Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 4Health News:How Prepared are America's Communities to Handle the Aging Boom? 2Health News:How Prepared are America's Communities to Handle the Aging Boom? 3Health News:How Prepared are America's Communities to Handle the Aging Boom? 4
Mounted on a fully adjustable molded,headband with crown strap and comfort,cushions, the sturdy Halogen III Classic is,lightweight, comfortable and durable....
... InterGro DBM putty is a product ... trusted names in human tissue processing, ... bone grafting technology. InterGro combines ... carrier (lecithin) to deliver a unique ...
... The UrinQuick Urine Chemistry Analyzer is a ... of urine test strips. The UrinQuick is ... QuickVue UrinChek 10+ SG and QuickVue UrinChek ... the urine test strips by reflectance spectrophotometry. ...
The NOW Flu A test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results and tre...
Medicine Products: